Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Discussion session - Public health policy

4536 - Cascade BRCA Germline Mutation (BGM) Testing of women with Breast (BC) or Epithelial Ovarian Cancer( EOC) and their families with subsequent Risk Reducing Surgery(RRS): A Canadian Economics Model

Date

20 Oct 2018

Session

Poster Discussion session - Public health policy

Topics

Cancer Prevention;  Bioethical Principles and GCP;  Targeted Therapy;  Genetic and Genomic Testing, Counseling

Tumour Site

Ovarian Cancer;  Breast Cancer

Presenters

paul Hoskins

Citation

Annals of Oncology (2018) 29 (suppl_8): viii562-viii575. 10.1093/annonc/mdy297

Authors

P. Hoskins1, A. Ecclestone2, M. Hurry3, M. Dyer4

Author affiliations

  • 1 Medical Oncology, BC Cancer Agency, V5Z 1L3 - Vancouver/CA
  • 2 Statistics, DRG Abacus, manchester/GB
  • 3 Health Economics, AstraZeneca Canada, L4Y 1M4 - Mississauga/CA
  • 4 Health Economics, AstraZeneca Academy House, CB2 1PG - Cambridge/GB
More

Resources

Abstract 4536

Background

Targeted prevention by RRS in mutation carriers ( first test the index case with BC or EOC and , if positive, their family ) saves lives. BGMs rates: EOC (12 - 18%), BC ( 1- 5%). BRCA1 carriers have a 35 - 60% EOC risk and 65% for BC; BRCA2 12- 25% and 45% respectively. RRS prevents 80-90%. Does this also represent value for money compared to no prevention with treatment upon occurrence?

Methods

A patient level simulation was used: 50 yr time frame and all cause mortality endpoint. Assumptions: 1) all index cases and female family had BGM 2) all unaffected carriers had RRS – bilateral salpingo-oopherectomy (RRBSO) and bilateral mastectomy (RRM) 3) 26,316 and 2786 BC and EOC per year in Canada 4) BGM rate in EOC 12.6% ( 61.6% BRCA1; 38.4% BRCA 2) ; 4.7% in BC ( 51% BRCA1, 49% BRCA2) 5) test 10 relatives if index case positive ( 50% risk) and test 20 if 10 positive (25% risk) 6) prevention by RRS for EOC is 84% and 90% for BC 7) Standard therapy cures 50% EOC and 90% of BC. Costs: BRCA testing/counselling $1000; RRBSO $9080; RRM $5833; EOC chemotherapy $34,412 / year and BC one time cost $23,796; palliative care costs EOC $14,687, BC $29,993. Cancer -related utilities 0.5 to 0.72 for EOC and BC 0.71 to 0.77 .

Results

29,102 index cases (1yr). 1668 had BRCA mutation as did 1593 10 and 275 200 relatives. Cases prevented: EOC 270 and BC 426. Total 50 year cost for testing/RRS cohort was $255 million and $285 million in the control cohort. ICER ( incremental cost effectiveness ratio) was - $7901 per quality adjusted life year ( dominant). Sensitivity analyses showed less cost effective ICER as testing /RRS rates fell. At real world rates e.g. 44% RRBSO and 21% RRM, ICER was $20,176. All probabilistic sensitivity analyses remained in the cost-effective quadrant (North American ICER < $100,000).

Conclusions

Targeting the high risk for RRS saves lives and is cost-effective under a wide range of inputs. These data are conservative as excluded are the indirect costs of treatment i.e. family/societal costs and increasing drug costs. Healthcare systems must ensure as close to 100% BGM / RRS rates as this saves the most lives,is cost efficacious and also saves money.

Clinical trial identification

Legal entity responsible for the study

Paul Hoskins.

Funding

AstraZeneca.

Editorial Acknowledgement

not applicable

Disclosure

P. Hoskins: Advisory boards: AstraZeneca, Roche, Pfizer, Purdue. A. Ecclestone: Funding to do analysis for this paper: AstraZeneca. M. Hurry, M. Dyer: Employee: AstraZeneca.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.